Gene-Yuan Chang, MD
Nephrology · San Leandro
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 21
- 5 carriers
- Office
- 1
- Since medical school
- 17 years
- Boston University School of Medicine, 2009
Offices
1 location · West Coast Kidney · 56 clinicians in this group
Looking this up.
Hospitals listed: 052685 · 552633 · 752527 · Eden Medical Center · Highland Hospital. That is not proof they admit you there this week.
Plans that list them
21 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chang’s office at (510) 351-9373 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
21 of 21 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A121677 · Current
Licensed to practise in California · since 2012 · expires 2028-05-31 · Boston University School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Nephrology
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
- Highland HospitalOakland, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Alameda Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.568, Oct 2024 – Sep 2025
See every measure and the patient survey for Eden Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.122 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 819 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.46 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.41 (92.94 to 181.88) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,714 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 4,676 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 860 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.17 to 4.32) · 818 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.76 (0 to 15.78) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.12) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,132 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 60 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.307 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.4 · 367 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 390 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.4) · 68 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 205 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Highland Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 5 the same, 1 worse of 6 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.568 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 487 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.7 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.35 (145.43 to 251.26) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 83 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.3 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.9 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 68 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 1,143 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.38) · 4,370 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.47) · 4,344 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.54 (0.29 to 4.79) · 689 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.07 (0.37 to 3.78) · 165 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.91 (0.34 to 3.48) · 681 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.62 (2.72 to 20.53) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.44 (1.37 to 9.5) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.97 (0.49 to 3.45) · 126 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.76 (0.07 to 1.44) · 3,387 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.519 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.682 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 51 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 184 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 141.8 · 59 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 27.6 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 35.3 · 253 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 243 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.2 to 7.7) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (9.7 to 18.5) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.4 (10.8 to 19.4) · 355 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 84 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,960 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
Original Medicare doctor bills
$241,178
Medicare paid this office $241,178 for 436 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 38 | $80,309 | $319 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 200 | $34,025 | $69 |
| Return visit (30+ min) | 108 | $23,197 | $105 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 143 | $17,843 | $114 |
| Long return visit (40+ min) | 60 | $16,955 | $151 |
See all 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 38 | $80,309 | $319 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 200 | $34,025 | $69 |
| Return visit (30+ min) | 108 | $23,197 | $105 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 143 | $17,843 | $114 |
| Long return visit (40+ min) | 60 | $16,955 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 76 | $16,798 | $104 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 27 | $14,375 | $266 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 19 | $5,149 | $59 |
| Telephone medical discussion with physician, 5-10 minutes | 64 | $4,858 | $51 |
| Hemodialysis procedure with physician evaluation | 35 | $2,752 | $63 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 102 | $2,513 | $14 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 19 | $2,391 | $46 |
| New patient visit (45+ min) | 15 | $2,038 | $136 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | $1,966 | $73 |
Who their Medicare patients are
436 Original Medicare patients in 2024. Average age 73 · Under 65 17% · 85 and older 17% · Women 47% · Also on Medicaid 59% · Health risk score 4.66. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 64% · Heart failure 55% · Coronary heart disease 47% · Atrial fibrillation 32% · Depression 28% · Stroke 27% · COPD 26% · Dementia 19% · Cancer 15%.
The office billed $635,134, Medicare allowed $311,989 and paid $241,178; for 2,065 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 436 | 2,065 | 73 | 4.66 | $635,134 | $241,178 |
| 2023 | 493 | 1,816 | 74 | 4.66 | $611,504 | $234,890 |
| 2022 | 480 | 1,918 | 72 | 4.76 | $627,344 | $229,255 |
| 2021 | 435 | 1,685 | 73 | 4.20 | $506,401 | $203,586 |
| 2020 | 435 | 1,590 | 73 | 4.66 | $439,071 | $169,372 |
| 2019 | 437 | 1,753 | 73 | 4.75 | $455,130 | $174,107 |
| 2018 | 458 | 1,831 | 72 | 4.72 | $448,937 | $168,728 |
| 2017 | 439 | 1,981 | 73 | 4.74 | $450,227 | $172,981 |
| 2016 | 268 | 870 | 71 | 4.15 | $195,707 | $73,672 |
| 2015 | 42 | 78 | 70 | 1.94 | $46,933 | $6,207 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 45 | $86,516 | $322 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 249 | $38,546 | $71 |
| Return visit (30+ min) | 127 | $26,246 | $94 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 172 | $22,242 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $16,253 | $106 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 28 | $12,383 | $263 |
| Long return visit (40+ min) | 46 | $8,696 | $106 |
| New patient visit (45+ min) | 21 | $3,274 | $156 |
| Hemodialysis procedure with physician evaluation | 33 | $2,389 | $65 |
| Telephone medical discussion with physician, 11-20 minutes | 24 | $1,833 | $59 |
| Telephone medical discussion with physician, 5-10 minutes | 17 | $832 | $40 |
2022: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 38 | $75,388 | $322 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 229 | $40,628 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 163 | $22,261 | $120 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 32 | $20,341 | $257 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 90 | $18,069 | $91 |
| Long return visit (40+ min) | 64 | $13,995 | $90 |
| Return visit (30+ min) | 83 | $12,481 | $83 |
| Dialysis services, 1 physician visit per month (20 years or older) | 11 | $7,509 | $183 |
| Hemodialysis procedure with physician evaluation | 38 | $3,642 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,295 | $177 |
| New patient visit (45+ min) | 15 | $2,190 | $146 |
| Short return visit (20+ min) | 13 | $1,489 | $74 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $946 | $43 |
2021: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 28 | $48,044 | $325 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 227 | $35,225 | $65 |
| Return visit (30+ min) | 107 | $24,144 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 96 | $22,548 | $94 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 155 | $21,092 | $122 |
| Long return visit (40+ min) | 49 | $15,733 | $161 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 28 | $15,299 | $268 |
| Hemodialysis procedure with physician evaluation | 29 | $2,646 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,539 | $181 |
| New patient visit (45+ min) | 15 | $2,036 | $136 |
2020: 12 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 32 | $35,839 | $258 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 229 | $34,901 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 103 | $21,927 | $94 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 155 | $20,503 | $121 |
| Return visit (30+ min) | 97 | $17,416 | $90 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 23 | $13,552 | $215 |
| Dialysis services, 1 physician visit per month (20 years or older) | 12 | $8,194 | $164 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,672 | $184 |
| Hemodialysis procedure with physician evaluation | 38 | $3,449 | $66 |
| Long return visit (40+ min) | 15 | $2,352 | $138 |
| New patient visit (45+ min) | 16 | $2,225 | $139 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $1,364 | $65 |
2019: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 256 | $44,004 | $63 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 30 | $37,632 | $256 |
| Return visit (30+ min) | 121 | $25,513 | $90 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 161 | $21,773 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 64 | $14,533 | $92 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 24 | $14,030 | $216 |
| Hemodialysis procedure with physician evaluation | 41 | $3,496 | $64 |
2018: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 283 | $51,390 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 182 | $26,430 | $118 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 22 | $26,268 | $248 |
| Return visit (30+ min) | 101 | $23,760 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 80 | $17,533 | $89 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 19 | $9,932 | $211 |
| Hemodialysis procedure with physician evaluation | 56 | $6,238 | $62 |
| New patient visit (45+ min) | 13 | $1,925 | $148 |
2017: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 278 | $50,980 | $63 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 25 | $30,449 | $248 |
| Return visit (30+ min) | 90 | $22,132 | $93 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 142 | $19,166 | $118 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 24 | $15,863 | $212 |
| Hemodialysis procedure with physician evaluation | 70 | $7,677 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $7,669 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,794 | $166 |
| New patient visit (45+ min) | 23 | $3,399 | $148 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $965 | $88 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $921 | $34 |
| Manual urinalysis test with examination using microscope, non-automated | 25 | $102 | $4 |
2016: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 141 | $23,188 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $14,088 | $174 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 16 | $12,894 | $248 |
| Return visit (30+ min) | 41 | $4,627 | $93 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 14 | $3,552 | $209 |
| New patient visit (45+ min) | 19 | $2,766 | $146 |
| Hemodialysis procedure with physician evaluation | 26 | $2,498 | $62 |
| Return visit (30+ min) | 22 | $1,965 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,789 | $85 |
| Long return visit (40+ min) | 15 | $1,778 | $85 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $673 | $34 |
| Manual urinalysis test with examination using microscope, non-automated | 15 | $63 | $4 |
2015: 1 service
| Return visit (30+ min) | 27 | $2,819 | $67 |
Medicaid work
$46,363 in 2024
Medicaid paid $46,363 for 617 billed services this clinician did in 2024, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 218 | $29,920 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 326 | $11,969 |
| Return visit (30+ min) | 73 | $4,475 |
| 2024 | 617 | 3 | 27 | $46,363 |
| 2023 | 860 | 4 | 28 | $60,180 |
| 2022 | 1,797 | 6 | 35 | $36,109 |
| 2021 | 1,079 | 7 | 38 | $42,311 |
| 2020 | 941 | 7 | 29 | $45,084 |
| 2019 | 1,037 | 6 | 35 | $46,271 |
| 2018 | 1,050 | 6 | 41 | $38,434 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 196 | $33,537 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 511 | $17,735 |
| Return visit (30+ min) | 136 | $8,287 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 17 | $622 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 152 | $16,098 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 631 | $14,188 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 87 | $2,996 |
| Return visit (30+ min) | 41 | $1,955 |
| Injection, epoetin alfa, 100 units (for esrd on dialysis) | 61 | $872 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 825 | $0 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 207 | $20,089 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 536 | $9,803 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 126 | $4,786 |
| Return visit (30+ min) | 75 | $3,257 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 110 | $2,403 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 12 | $1,893 |
| Long return visit (40+ min) | 13 | $81 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 158 | $19,107 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 527 | $15,017 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 64 | $3,537 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 93 | $3,262 |
| Return visit (30+ min) | 69 | $2,474 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 15 | $1,341 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 15 | $347 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 156 | $21,561 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 637 | $15,034 |
| Return visit (30+ min) | 143 | $5,031 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 39 | $3,296 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 17 | $929 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 45 | $421 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 128 | $17,937 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 738 | $14,237 |
| Return visit (30+ min) | 110 | $3,746 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 15 | $1,038 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 20 | $777 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 39 | $700 |
Drugs they prescribed that Part D paid
$681,196
Pharmacies billed $681,196 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,018) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
1,739 generic and 279 brand-name prescriptions · $681,196 in drug cost · 40 antibiotic prescriptions to 22 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tarpeyo | 14 | $227,156 | $16,225 |
| Filspari | 12 | $133,221 | $11,102 |
| Rayaldee | 49 | $60,882 | $1,242 |
| Xphozah | 16 | $50,596 | $3,162 |
| Farxiga | 59 | $44,192 | $749 |
See all 51 drugs
| Tarpeyo | 14 | $227,156 | $16,225 |
| Filspari | 12 | $133,221 | $11,102 |
| Rayaldee | 49 | $60,882 | $1,242 |
| Xphozah | 16 | $50,596 | $3,162 |
| Farxiga | 59 | $44,192 | $749 |
| Veltassa | 28 | $35,602 | $1,271 |
| Cinacalcet | 17 | $10,639 | $626 |
| Lokelma | 12 | $9,493 | $791 |
| Sevelamer Carbonate | 30 | $7,113 | $237 |
| Tradjenta | 12 | $6,201 | $517 |
| Potassium Chloride | 21 | $4,470 | $213 |
| Bumetanide | 113 | $4,258 | $38 |
| Potassium Citrate Er | 22 | $2,465 | $112 |
| Eplerenone | 43 | $2,061 | $48 |
| Calcium Acetate | 21 | $1,973 | $94 |
| Valsartan | 59 | $1,329 | $23 |
| Hydralazine | 77 | $996 | $13 |
| Candesartan Cilexetil | 22 | $958 | $44 |
| Tamsulosin | 57 | $918 | $16 |
| Chlorthalidone | 40 | $878 | $22 |
| Metoprolol | 46 | $874 | $19 |
| Famotidine | 55 | $872 | $16 |
| Carvedilol | 108 | $718 | $7 |
| Doxazosin Mesylate | 34 | $689 | $20 |
| Allopurinol | 70 | $632 | $9 |
| Sodium Polystyrene Sulfonate | 11 | $617 | $56 |
| Amiodarone | 12 | $616 | $51 |
| Spironolactone | 64 | $599 | $9 |
| Midodrine | 12 | $563 | $47 |
| Furosemide | 95 | $562 | $6 |
| Diltiazem 24hr Er (Cd) | 22 | $492 | $22 |
| Lisinopril | 98 | $474 | $5 |
| Amlodipine Besylate | 84 | $439 | $5 |
| Calcitriol | 26 | $430 | $17 |
| Nifedipine Er | 11 | $415 | $38 |
| Klor-Con 10 | 16 | $307 | $19 |
| Losartan | 43 | $303 | $7 |
| Rosuvastatin | 11 | $283 | $26 |
| Pantoprazole | 19 | $266 | $14 |
| Colchicine | 13 | $260 | $20 |
| Metolazone | 19 | $226 | $12 |
| Bupropion Xl | 14 | $187 | $13 |
| Ondansetron | 11 | $154 | $14 |
| Atorvastatin | 31 | $142 | $5 |
| Oxybutynin Chloride Er | 12 | $133 | $11 |
| Sulfamethoxazole-Trimethoprim | 17 | $112 | $7 |
| Prednisone | 22 | $88 | $4 |
| Metoclopramide | 28 | $64 | $2 |
| Clonidine | 20 | $56 | $3 |
| Verapamil Er | 12 | $48 | $4 |
| Irbesartan | 11 | $24 | $2 |
Year by year
| 2024 | 2,018 | 202 | 0% (0) | 14% | $681,196 |
| 2023 | 1,671 | 193 | 0% (0) | None | $353,440 |
| 2022 | 1,447 | 162 | None | None | $264,789 |
| 2021 | 1,294 | 143 | None | None | $144,784 |
| 2020 | 1,355 | 138 | None | None | $170,652 |
| 2019 | 1,572 | 131 | None | None | $239,393 |
| 2018 | 1,564 | 108 | None | None | $259,894 |
| 2017 | 1,226 | 112 | None | None | $181,539 |
| 2016 | 421 | 85 | None | 11% | $21,015 |
| 2015 | 277 | 40 | 0% (0) | 13% | $16,771 |
| 2014 | 105 | 28 | 0% (0) | None | $9,833 |
| 2013 | 77 | 18 | 0% (0) | 19% | $3,286 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 40 drugs
| Rayaldee | 66 | $82,509 | $1,250 |
| Velphoro | 12 | $45,329 | $3,777 |
| Farxiga | 43 | $34,163 | $794 |
| Lokelma | 23 | $21,805 | $948 |
| Sevelamer Carbonate | 25 | $11,778 | $471 |
| Renvela | 11 | $10,199 | $927 |
| Cinacalcet | 31 | $7,844 | $253 |
| Bumetanide | 85 | $5,062 | $60 |
| Valsartan | 29 | $2,354 | $81 |
| Midodrine | 21 | $2,048 | $98 |
| Calcium Acetate | 20 | $1,889 | $94 |
| Carvedilol | 110 | $1,480 | $13 |
| Eplerenone | 28 | $1,409 | $50 |
| Potassium Citrate Er | 16 | $1,363 | $85 |
| Olmesartan Medoxomil | 22 | $1,226 | $56 |
| Rosuvastatin | 28 | $1,110 | $40 |
| Tamsulosin | 50 | $1,104 | $22 |
| Hydralazine | 59 | $1,073 | $18 |
| Amlodipine Besylate | 83 | $1,000 | $12 |
| Chlorthalidone | 45 | $834 | $19 |
| Diltiazem 24hr Er (Cd) | 20 | $805 | $40 |
| Potassium Chloride | 18 | $798 | $44 |
| Telmisartan | 11 | $710 | $65 |
| Doxazosin Mesylate | 41 | $580 | $14 |
| Famotidine | 36 | $534 | $15 |
| Allopurinol | 40 | $528 | $13 |
| Furosemide | 61 | $468 | $8 |
| Atorvastatin | 40 | $463 | $12 |
| Lisinopril | 68 | $445 | $7 |
| Metoprolol | 23 | $436 | $19 |
| Spironolactone | 51 | $408 | $8 |
| Clonidine | 38 | $376 | $10 |
| Losartan | 27 | $374 | $14 |
| Calcitriol | 17 | $344 | $20 |
| Bupropion Xl | 12 | $303 | $25 |
| Pantoprazole | 19 | $300 | $16 |
| Metoclopramide | 23 | $221 | $10 |
| Levothyroxine | 12 | $202 | $17 |
| Prednisone | 15 | $101 | $7 |
| Sulfamethoxazole-Trimethoprim | 19 | $80 | $4 |
2022: 33 drugs
| Rayaldee | 48 | $59,106 | $1,231 |
| Velphoro | 21 | $59,083 | $2,813 |
| Farxiga | 43 | $28,486 | $662 |
| Lokelma | 30 | $28,379 | $946 |
| Sevelamer Carbonate | 23 | $6,789 | $295 |
| Cinacalcet | 30 | $5,904 | $197 |
| Tacrolimus | 11 | $5,885 | $535 |
| Bumetanide | 69 | $4,615 | $67 |
| Midodrine | 22 | $3,969 | $180 |
| Calcium Acetate | 24 | $2,259 | $94 |
| Chlorthalidone | 37 | $1,461 | $39 |
| Carvedilol | 102 | $1,230 | $12 |
| Hydralazine | 42 | $886 | $21 |
| Labetalol | 17 | $859 | $51 |
| Doxazosin Mesylate | 33 | $765 | $23 |
| Amlodipine Besylate | 123 | $700 | $6 |
| Tamsulosin | 44 | $644 | $15 |
| Spironolactone | 39 | $618 | $16 |
| Famotidine | 43 | $608 | $14 |
| Atorvastatin | 41 | $556 | $14 |
| Losartan | 23 | $543 | $24 |
| Allopurinol | 36 | $467 | $13 |
| Metoprolol | 16 | $376 | $23 |
| Lisinopril | 78 | $375 | $5 |
| Rosuvastatin | 11 | $354 | $32 |
| Furosemide | 52 | $314 | $6 |
| Calcitriol | 13 | $277 | $21 |
| Oxybutynin Chloride | 17 | $263 | $15 |
| Metoclopramide | 23 | $260 | $11 |
| Prednisone | 18 | $166 | $9 |
| Clonidine | 18 | $162 | $9 |
| Sulfamethoxazole-Trimethoprim | 15 | $41 | $3 |
| Omeprazole | 13 | $13 | $1 |
2021: 35 drugs
| Rayaldee | 28 | $41,433 | $1,480 |
| Renvela | 11 | $17,241 | $1,567 |
| Farxiga | 18 | $11,226 | $624 |
| Prosol | 30 | $4,834 | $161 |
| Cinacalcet | 17 | $3,196 | $188 |
| Bumetanide | 45 | $3,055 | $68 |
| Calcium Acetate | 20 | $2,494 | $125 |
| Labetalol | 16 | $1,767 | $110 |
| Midodrine | 13 | $1,691 | $130 |
| Chlorthalidone | 35 | $1,446 | $41 |
| Colchicine | 14 | $1,201 | $86 |
| Hydralazine | 61 | $1,154 | $19 |
| Famotidine | 51 | $913 | $18 |
| Metolazone | 14 | $896 | $64 |
| Spironolactone | 37 | $838 | $23 |
| Doxazosin Mesylate | 18 | $834 | $46 |
| Potassium Chloride | 28 | $693 | $25 |
| Amlodipine Besylate | 94 | $623 | $7 |
| Allopurinol | 31 | $585 | $19 |
| Metoprolol | 20 | $585 | $29 |
| Carvedilol | 73 | $585 | $8 |
| Atorvastatin | 32 | $518 | $16 |
| Calcitriol | 22 | $380 | $17 |
| Clonidine | 20 | $377 | $19 |
| Losartan | 37 | $376 | $10 |
| Lidocaine-Prilocaine | 23 | $362 | $16 |
| Finasteride | 20 | $309 | $15 |
| Lisinopril | 49 | $262 | $5 |
| Furosemide | 51 | $252 | $5 |
| Nitrofurantoin Mono-Macro | 11 | $239 | $22 |
| Cyclobenzaprine | 15 | $187 | $12 |
| Prednisone | 12 | $178 | $15 |
| Mirtazapine | 11 | $158 | $14 |
| Tamsulosin | 20 | $118 | $6 |
| Metoclopramide | 11 | $31 | $3 |
2020: 38 drugs
| Rayaldee | 48 | $69,471 | $1,447 |
| Velphoro | 13 | $23,069 | $1,775 |
| Veltassa | 20 | $18,893 | $945 |
| Eliquis | 11 | $4,960 | $451 |
| Cinacalcet | 16 | $4,146 | $259 |
| Bumetanide | 44 | $3,098 | $70 |
| Calcium Acetate | 33 | $2,624 | $80 |
| Prosol | 18 | $2,591 | $144 |
| Sevelamer Carbonate | 13 | $2,349 | $181 |
| Chlorthalidone | 50 | $2,256 | $45 |
| Bystolic | 12 | $2,239 | $187 |
| Labetalol | 22 | $1,546 | $70 |
| Metolazone | 16 | $1,304 | $81 |
| Hydralazine | 56 | $1,057 | $19 |
| Metoprolol | 41 | $1,032 | $25 |
| Allopurinol | 47 | $821 | $17 |
| Losartan | 68 | $796 | $12 |
| Famotidine | 41 | $784 | $19 |
| Doxazosin Mesylate | 31 | $768 | $25 |
| Spironolactone | 37 | $738 | $20 |
| Amlodipine Besylate | 87 | $656 | $8 |
| Nitrofurantoin Mono-Macro | 13 | $589 | $45 |
| Carvedilol | 53 | $405 | $8 |
| Lidocaine-Prilocaine | 26 | $398 | $15 |
| Potassium Chloride | 16 | $364 | $23 |
| Furosemide | 67 | $350 | $5 |
| Clonidine | 18 | $320 | $18 |
| Atorvastatin | 22 | $281 | $13 |
| Finasteride | 12 | $264 | $22 |
| Calcitriol | 15 | $234 | $16 |
| Tamsulosin | 19 | $200 | $11 |
| Lisinopril | 27 | $179 | $7 |
| Prednisone | 22 | $174 | $8 |
| Ondansetron | 11 | $167 | $15 |
| Gabapentin | 20 | $123 | $6 |
| Duloxetine | 11 | $117 | $11 |
| Pantoprazole | 16 | $96 | $6 |
| Clonazepam | 12 | $70 | $6 |
2019: 42 drugs
| Rayaldee | 46 | $59,304 | $1,289 |
| Velphoro | 22 | $44,916 | $2,042 |
| Veltassa | 30 | $26,755 | $892 |
| Sevelamer Carbonate | 17 | $24,391 | $1,435 |
| Prosol | 41 | $8,203 | $200 |
| Eplerenone | 21 | $7,069 | $337 |
| Bumetanide | 36 | $2,927 | $81 |
| Potassium Chloride | 18 | $2,646 | $147 |
| Metolazone | 36 | $1,964 | $55 |
| Calcium Acetate | 29 | $1,841 | $63 |
| Chlorthalidone | 30 | $1,455 | $49 |
| Doxazosin Mesylate | 50 | $1,153 | $23 |
| Hydralazine | 64 | $1,069 | $17 |
| Labetalol | 15 | $1,033 | $69 |
| Midodrine | 12 | $913 | $76 |
| Allopurinol | 58 | $826 | $14 |
| Losartan | 71 | $777 | $11 |
| Spironolactone | 38 | $753 | $20 |
| Calcitriol | 28 | $662 | $24 |
| Metoprolol | 31 | $651 | $21 |
| Nitrofurantoin Mono-Macro | 15 | $617 | $41 |
| Famotidine | 51 | $586 | $11 |
| Amlodipine Besylate | 96 | $564 | $6 |
| Furosemide | 96 | $520 | $5 |
| Carvedilol | 63 | $501 | $8 |
| Clonidine | 25 | $412 | $16 |
| Lidocaine-Prilocaine | 25 | $398 | $16 |
| Finasteride | 15 | $351 | $23 |
| Lisinopril | 69 | $325 | $5 |
| Isosorbide Mononitrate Er | 14 | $299 | $21 |
| Atorvastatin | 24 | $294 | $12 |
| Irbesartan | 11 | $286 | $26 |
| Quetiapine | 11 | $259 | $24 |
| Gabapentin | 27 | $207 | $8 |
| Sumatriptan | 15 | $195 | $13 |
| Ondansetron | 22 | $195 | $9 |
| Ranitidine | 14 | $152 | $11 |
| Tamsulosin | 12 | $138 | $12 |
| Omeprazole | 13 | $137 | $11 |
| Oxybutynin Chloride Er | 11 | $101 | $9 |
| Lovastatin | 12 | $55 | $5 |
| Clonazepam | 11 | $50 | $5 |
2018: 44 drugs
| Velphoro | 17 | $32,291 | $1,899 |
| Sevelamer Carbonate | 28 | $28,769 | $1,027 |
| Rayaldee | 26 | $26,271 | $1,010 |
| Veltassa | 29 | $25,518 | $880 |
| Renvela | 14 | $20,646 | $1,475 |
| Sensipar | 17 | $14,444 | $850 |
| Prosol | 13 | $2,432 | $187 |
| Doxazosin Mesylate | 78 | $2,383 | $31 |
| Chlorthalidone | 39 | $1,769 | $45 |
| Eplerenone | 13 | $1,698 | $131 |
| Bumetanide | 31 | $1,682 | $54 |
| Metolazone | 24 | $1,121 | $47 |
| Spironolactone | 98 | $1,056 | $11 |
| Allopurinol | 65 | $800 | $12 |
| Potassium Chloride | 14 | $790 | $56 |
| Calcitriol | 45 | $775 | $17 |
| Midodrine | 13 | $733 | $56 |
| Calcium Acetate | 12 | $707 | $59 |
| Nitrofurantoin Mono-Macro | 14 | $653 | $47 |
| Amiloride | 17 | $647 | $38 |
| Hydralazine | 57 | $635 | $11 |
| Metoprolol | 31 | $586 | $19 |
| Lidocaine-Prilocaine | 24 | $525 | $22 |
| Valsartan | 20 | $488 | $24 |
| Amlodipine Besylate | 102 | $446 | $4 |
| Furosemide | 93 | $380 | $4 |
| Carvedilol | 74 | $373 | $5 |
| Metoclopramide | 31 | $332 | $11 |
| Tamsulosin | 23 | $284 | $12 |
| Lisinopril | 58 | $270 | $5 |
| Atorvastatin | 18 | $247 | $14 |
| Levothyroxine | 12 | $235 | $20 |
| Gabapentin | 24 | $230 | $10 |
| Finasteride | 14 | $212 | $15 |
| Losartan | 30 | $175 | $6 |
| Omeprazole | 15 | $155 | $10 |
| Clonidine | 15 | $148 | $10 |
| Prednisone | 11 | $147 | $13 |
| Ranitidine | 12 | $119 | $10 |
| Famotidine | 11 | $95 | $9 |
| Sertraline | 16 | $86 | $5 |
| Quetiapine | 14 | $76 | $5 |
| Clonazepam | 12 | $74 | $6 |
| Trazodone | 12 | $37 | $3 |
2017: 34 drugs
| Renvela | 34 | $47,593 | $1,400 |
| Sensipar | 28 | $29,366 | $1,049 |
| Sevelamer Carbonate | 11 | $6,872 | $625 |
| Chlorthalidone | 56 | $2,262 | $40 |
| Doxazosin Mesylate | 52 | $1,802 | $35 |
| Bumetanide | 36 | $1,258 | $35 |
| Isosorbide Dinitrate | 16 | $972 | $61 |
| Calcium Acetate | 11 | $807 | $73 |
| Metolazone | 15 | $648 | $43 |
| Spironolactone | 60 | $626 | $10 |
| Valsartan | 15 | $621 | $41 |
| Terazosin | 18 | $602 | $33 |
| Nifedipine Er | 12 | $493 | $41 |
| Tamsulosin | 21 | $456 | $22 |
| Carvedilol | 72 | $368 | $5 |
| Calcitriol | 24 | $366 | $15 |
| Polyethylene Glycol 3350 | 13 | $343 | $26 |
| Metoprolol | 18 | $340 | $19 |
| Amlodipine Besylate | 82 | $326 | $4 |
| Hydralazine | 21 | $323 | $15 |
| Lisinopril | 57 | $320 | $6 |
| Losartan | 53 | $315 | $6 |
| Atorvastatin | 14 | $280 | $20 |
| Furosemide | 88 | $276 | $3 |
| Allopurinol | 15 | $258 | $17 |
| Klor-Con Sprinkle | 11 | $237 | $22 |
| Finasteride | 14 | $216 | $15 |
| Metoclopramide | 17 | $207 | $12 |
| Clonidine | 21 | $115 | $5 |
| Gabapentin | 17 | $97 | $6 |
| Ranitidine | 11 | $88 | $8 |
| Famotidine | 15 | $40 | $3 |
| Clonazepam | 11 | $36 | $3 |
| Hydrochlorothiazide | 13 | $32 | $2 |
2016: 10 drugs
| Tamsulosin | 20 | $1,020 | $51 |
| Chlorthalidone | 20 | $1,003 | $50 |
| Calcitriol | 13 | $317 | $24 |
| Doxazosin Mesylate | 16 | $292 | $18 |
| Amlodipine Besylate | 59 | $259 | $4 |
| Furosemide | 66 | $250 | $4 |
| Finasteride | 12 | $158 | $13 |
| Losartan | 24 | $148 | $6 |
| Lisinopril | 25 | $122 | $5 |
| Spironolactone | 11 | $93 | $8 |
2015: 9 drugs
| Doxercalciferol | 11 | $4,682 | $426 |
| Labetalol | 11 | $510 | $46 |
| Calcitriol | 19 | $474 | $25 |
| Finasteride | 22 | $340 | $15 |
| Chlorthalidone | 13 | $270 | $21 |
| Furosemide | 34 | $148 | $4 |
| Losartan | 17 | $142 | $8 |
| Amlodipine Besylate | 43 | $120 | $3 |
| Lisinopril | 20 | $83 | $4 |
2013: 1 drug
| Calcitriol | 11 | $290 | $26 |
Money from drug and device companies
$840 in 2025
| 2025 | 9 | 31 | None | $840 |
| 2024 | 10 | 30 | None | $711 |
| 2023 | 11 | 47 | None | $871 |
| 2022 | 11 | 22 | None | $447 |
| 2021 | 5 | 16 | None | $295 |
| 2020 | 3 | 21 | None | $340 |
| 2019 | 3 | 19 | None | $176 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $184 | 3 payments
|
| Amgen | Krystexxa | $145 | 9 payments
|
| Fresenius USA Marketing | Velphoro | $138 | 7 payments
|
| Ardelyx | Xphozah 30 Mg | $120 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $91 | 4 payments
|
| Otsuka America Pharmaceutical | Jynarque | $63 | 3 payments
|
See all 31 published payments
| Otsuka America Pharmaceutical | Meals · 2025-12-11 | Jynarque | $22 |
| Amgen | Meals · 2025-11-20 | Krystexxa | $10 |
| Amgen | Meals · 2025-11-06 | Krystexxa | $11 |
| Mallinckrodt Hospital Products | Meals · 2025-10-17 | Acthar | $26 |
| Fresenius USA Marketing | Meals · 2025-10-10 | Velphoro | $22 |
| Amgen | Meals · 2025-09-30 | Krystexxa | $9 |
| Ardelyx | Meals · 2025-09-25 | Xphozah 30 Mg | $120 |
| Novo Nordisk | Meals · 2025-08-21 | Wegovy | $31 |
| Amgen | Meals · 2025-08-13 | Krystexxa | $29 |
| Fresenius USA Marketing | Meals · 2025-08-06 | Velphoro | $22 |
| Amgen | Meals · 2025-07-29 | Krystexxa | $9 |
| Fresenius USA Marketing | Meals · 2025-07-28 | Velphoro | $25 |
| Otsuka America Pharmaceutical | Meals · 2025-07-09 | Jynarque | $24 |
| Amgen | Meals · 2025-07-08 | Krystexxa | $14 |
| Mallinckrodt Hospital Products | Meals · 2025-06-25 | Acthar | $21 |
| Fresenius USA Marketing | Meals · 2025-06-12 | Velphoro | $7 |
| Fresenius USA Marketing | Meals · 2025-06-12 | Velphoro | $16 |
| Amgen | Meals · 2025-05-08 | Tavneos | $28 |
| ANI Pharmaceuticals | Meals · 2025-04-28 | Purified Cortrophin Gel | $22 |
| Fresenius USA Marketing | Meals · 2025-04-21 | Velphoro | $25 |
| Novartis Pharmaceuticals | Meals · 2025-04-18 | Fabhalta | $14 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-18 | Kerendia | $27 |
| Novo Nordisk | Meals · 2025-04-15 | Ozempic | $28 |
| Mallinckrodt Hospital Products | Meals · 2025-04-14 | Acthar | $15 |
| Novo Nordisk | Meals · 2025-03-18 | Ozempic | $124 |
| Amgen | Meals · 2025-03-10 | Krystexxa | $11 |
| Fresenius USA Marketing | Meals · 2025-03-04 | Velphoro | $22 |
| Novartis Pharmaceuticals | Meals · 2025-02-24 | Fabhalta | $35 |
| Otsuka America Pharmaceutical | Meals · 2025-02-20 | Jynarque | $17 |
| Mallinckrodt Hospital Products | Meals · 2025-01-17 | Acthar | $30 |
| Amgen | Meals · 2025-01-13 | Krystexxa | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $711
| Amgen | Krystexxa | $355 | 14 payments
|
| Fresenius USA Marketing | Velphoro | $95 | 4 payments
|
| Otsuka America Pharmaceutical | Jynarque | $63 | 3 payments
|
| Ardelyx | Ibsrela | $46 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $44 | 2 payments
|
| Vifor Pharma | Veltassa | $24 | 1 payment
|
| Lilly USA | Jardiance | $23 | 1 payment
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $21 | 1 payment
|
| Novo Nordisk | Ozempic | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $19 | 1 payment
|
2023: $871
| Travere Therapeutics | None | $186 | 9 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $175 | 6 payments
|
| Otsuka America Pharmaceutical | Jynarque | $131 | 5 payments
|
| Horizon Therapeutics plc | Krystexxa | $117 | 6 payments
|
| GlaxoSmithKline | Benlysta | $105 | 5 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $42 | 2 payments
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $29 | 1 payment
|
| Vifor Pharma | Veltassa | $23 | 1 payment
|
| OPKO Pharmaceuticals | Rayaldee | $22 | 1 payment
|
| Ardelyx | Ibsrela | $21 | 1 payment
|
| Calliditas Therapeutics US | Tarpeyo | $19 | 1 payment
|
2022: $447
| Calliditas Therapeutics US | Tarpeyo | $129 | 7 payments
|
| GlaxoSmithKline | Benlysta | $64 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $55 | 3 payments
|
| Fresenius USA Marketing | Velphoro | $51 | 2 payments
|
| Horizon Therapeutics plc | Krystexxa | $24 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $24 | 1 payment
|
| Vifor Pharma | Veltassa | $22 | 1 payment
|
| Akebia Therapeutics | Auryxia | $21 | 1 payment
|
| OPKO Pharmaceuticals | Rayaldee | $20 | 1 payment
|
| Amgen | Tavneos | $20 | 1 payment
|
| Novo Nordisk | Ozempic | $18 | 1 payment
|
2021: $295
| AstraZeneca Pharmaceuticals LP | Lokelma | $191 | 11 payments
|
| Fresenius USA Marketing | Velphoro | $32 | 2 payments
|
| Daiichi Sankyo | Injectafer | $25 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $24 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $23 | 1 payment
|
2020: $340
| AstraZeneca Pharmaceuticals LP | Lokelma | $305 | 13 payments
|
| OPKO Pharmaceuticals | Rayaldee | $18 | 1 payment
|
| Amgen | Parsabiv | $16 | 1 payment
|
2019: $176
| AstraZeneca Pharmaceuticals LP | Lokelma | $145 | 5 payments
|
| Amgen | Parsabiv | $16 | 1 payment
|
| Akebia Therapeutics | Auryxia | $14 | 2 payments
|
Professional record
- NPI
- 1467731828
- Licence
- CA 121677California A121677: Current · expires 2028-05-31
- Trained
- Boston University School of Medicine, 2009 · 17 years ago
- Group
- West Coast Kidney
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 19850 Lake Chabot Rd, Castro Valley, CA, 94546
- NPI first listed
- 2011-08-16
- NPI last updated
- 2025-04-25
- NPI record certified
- 2025-04-25
This is when the NPI record was last certified, not a medical board exam.